A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_20522179 Show fit | 1.71 |
ENST00000359062.3
|
phosphodiesterase 3A, cGMP-inhibited |
|
chr3_-_112360116 Show fit | 1.46 |
ENST00000206423.3
ENST00000439685.2 |
coiled-coil domain containing 80 |
|
chr10_+_112631547 Show fit | 1.26 |
ENST00000280154.7
ENST00000393104.2 |
programmed cell death 4 (neoplastic transformation inhibitor) |
|
chrX_-_77041685 Show fit | 1.25 |
ENST00000373344.5
ENST00000395603.3 |
alpha thalassemia/mental retardation syndrome X-linked |
|
chr10_-_102046098 Show fit | 1.23 |
ENST00000441611.1
|
biogenesis of lysosomal organelles complex-1, subunit 2 |
|
chr1_-_51984908 Show fit | 1.17 |
ENST00000371730.2
|
epidermal growth factor receptor pathway substrate 15 |
|
chr1_-_185286461 Show fit | 1.10 |
ENST00000367498.3
|
influenza virus NS1A binding protein |
|
chr10_-_118032697 Show fit | 1.05 |
ENST00000439649.3
|
GDNF family receptor alpha 1 |
|
chr3_+_30648066 Show fit | 1.05 |
ENST00000359013.4
|
transforming growth factor, beta receptor II (70/80kDa) |
|
chr10_+_111767720 Show fit | 1.02 |
ENST00000356080.4
ENST00000277900.8 |
adducin 3 (gamma) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.0 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 1.5 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.0 | 1.4 | GO:0043297 | apical junction assembly(GO:0043297) |
0.4 | 1.3 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.4 | 1.3 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
0.2 | 1.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 1.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 1.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 1.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 1.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 1.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 1.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |